Search Results to Rhoda Alani, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Alani, Rhoda

Research Expertise & Professional Interests Rhoda M. Alani, MD is the Herbert Mescon Professor and Chair of Dermatology at Boston University School of Medicine and Boston Medical Center. She received her MD degree with Honors and Distinction in Research from the University of Michigan and completed her internship in internal medicine at Yale-New Haven Hospital and a residency in dermatology at Harvard Medical School. From 1999-2009 Dr. Alani was the Director of the Laboratory of Cutaneous Oncology and Director of the Melanoma and Pigmented Lesion Clinics in Dermatology at Johns Hopkins. Dr. Alani’s research focus is in understanding the molecular basis of melanoma development and progression with the aim of translating her laboratory findings to better prevention, detection, diagnosis, and treatment of melanoma. Dr. Alani is a member of Phi Beta Kappa and Alpha Omega Alpha Honor Societies, the American Academy of Dermatology, the Society for Investigative Dermatology, the American Association for Cancer Research and was elected to the American Society for Clinical Investigation in 2005. She is the author of numerous scientific publications and is the owner of several US patents related to melanoma biomarkers, novel melanoma therapies, and imaging systems for improved melanoma detection
Self-Described Keywords Melanoma
Self-Described Keywords Melanoma therapeutics
Self-Described Keywords Melanoma biology

One or more keywords matched the following items that are connected to Alani, Rhoda

Item TypeName
Concept Melanoma, Experimental
Academic Article Effects of thallium ion on cellular components of the skin.
Academic Article The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
Academic Article Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.
Academic Article Toward a molecular classification of melanoma.
Academic Article Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.
Academic Article BRAF kinase in melanoma development and progression.
Academic Article Id1 expression is transcriptionally regulated in radial growth phase melanomas.
Academic Article Melanoma biomarkers: current status and vision for the future.
Academic Article Glyceraldehyde-3-phosphate dehydrogenase expression is altered by hypoxia in melanoma cells and primary human melanocytes.
Academic Article Cigarette smoking and malignant melanoma: a case-control study.
Academic Article Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.
Academic Article Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.
Academic Article Global analysis of BRAFV600E target genes in human melanocytes identifies matrix metalloproteinase-1 as a critical mediator of melanoma growth.
Academic Article Neuropilin-2: a novel biomarker for malignant melanoma?
Academic Article A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer.
Academic Article A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype.
Academic Article MicroRNAs as an emerging target for melanoma therapy.
Academic Article Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.
Academic Article Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma.
Academic Article Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration.
Academic Article MC1R is a potent regulator of PTEN after UV exposure in melanocytes.
Academic Article A simple engineered platform reveals different modes of tumor-microenvironmental cell interaction.
Academic Article Neuropilin-2 promotes melanoma growth and progression in vivo.
Academic Article Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis.
Academic Article Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.
Academic Article Quantitative assessment of neuropilin-2 as a simple and sensitive diagnostic assay for spitzoid melanocytic lesions.
Academic Article Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
Academic Article Emerging Biomarkers in Cutaneous Melanoma.
Award or Honor Receipt Scholar Award for Melanoma Research
Academic Article Defining the role of hypoxia in melanoma development and response to therapy
Academic Article Defining the role of Id1 in melanoma development and progression
Academic Article Towards a Molecular Classification of Melanoma
Academic Article Clinical Oncology (Abeloff, M.D., et. al, eds.)
Academic Article Clinical Oncology (Abeloff, M.D., et. al)
Academic Article Society for Melanoma Research International Melanoma Congress
Academic Article Society for Melanoma Research International Melanoma Congress
Academic Article Society for Melanoma Research International Melanoma Congress
Academic Article American Federation for Medical Research-Eastern Regional Meeting
Academic Article United States and Canadian Academy of Pathology
Academic Article AACR
Academic Article Johns Hopkins Biotech 2007: Investing in Cancer Research
Academic Article Journal of Investigative Dermatology
Academic Article MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.
Grant Epigenetic Regulation of Resistance to Targeted Therapies in Melanoma
Grant Modeling the Metastasis of Malignant Melanoma Using Microfluidic Platforms
Grant Melanoma Assays Based on NRP-2
Grant Evaluating Melanoma Using Engineered Metastatic Platforms: A Potential for High Throughout Screening and Drug Discovery
Grant Targeting Transcriptional Co-repressor CoREST Complex in Melanoma

Search Criteria
  • Melanoma